Male breast cancer precursor lesions: analysis of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program.

Saved in:
Bibliographic Details
Title: Male breast cancer precursor lesions: analysis of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program.
Authors: Doebar SC; Department of Pathology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Slaets L; The European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium., Cardoso F; Breast Unit, Champalimaud Clinical Center/Champalimaud Foundation, Lisbon, Portugal., Giordano SH; Departments of Health Services Research and Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Bartlett JM; Transformative Pathology, Ontario Institute for Cancer Research, Toronto, Canada & University of Edinburgh, Scotland, UK., Tryfonidis K; The European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium., Dijkstra NH; BOOG Study Center/Dutch Breast Cancer Research Group, Amsterdam, The Netherlands., Schröder CP; Department of Medical Oncology, University Medical Center Groningen, Groningen, The Netherlands.; BOOG Study Center/Dutch Breast Cancer Research Group, Amsterdam, The Netherlands., van Asperen CJ; Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands.; BOOG Study Center/Dutch Breast Cancer Research Group, Amsterdam, The Netherlands., Linderholm B; Department of Oncology, Swedish Association of Breast Oncologists (SABO), Sahlgrenska University Hospital, Gothenburg, Sweden., Benstead K; Department of Oncology, Cheltenham General Hospital, Gloucestershire, UK., Dinjens WN; Department of Pathology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., van Marion R; Department of Pathology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., van Diest PJ; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands., Martens JW; Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.; BOOG Study Center/Dutch Breast Cancer Research Group, Amsterdam, The Netherlands., van Deurzen CH; Department of Pathology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.; BOOG Study Center/Dutch Breast Cancer Research Group, Amsterdam, The Netherlands.
Source: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc [Mod Pathol] 2017 Apr; Vol. 30 (4), pp. 509-518. Date of Electronic Publication: 2017 Jan 13.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 8806605 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1530-0285 (Electronic) Linking ISSN: 08933952 NLM ISO Abbreviation: Mod Pathol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1530-0285
DOI:10.1038/modpathol.2016.229